2014
DOI: 10.1111/hepr.12366
|View full text |Cite
|
Sign up to set email alerts
|

Case of cholangiocellular carcinoma in a patient with glycogen storage disease type Ia

Abstract: Glycogen storage disease (GSD) type Ia is caused by a deficiency in glucose-6-phosphatase. Long-term complications, including renal disease, gout, osteoporosis and pulmonary hypertension, develop in patients with GSD type Ia. In the second or third decade, 22-75% of GSD type Ia patients develop hepatocellular adenoma (HCA). In some of these patients, the HCA evolves into hepatocellular carcinoma. However, little is known about GSD type Ia patients with HCA who develop cholangiocellular carcinoma (CCC). Here, w… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1

Citation Types

0
1
0

Year Published

2022
2022
2024
2024

Publication Types

Select...
3

Relationship

0
3

Authors

Journals

citations
Cited by 3 publications
(1 citation statement)
references
References 15 publications
0
1
0
Order By: Relevance
“…The incidence of GSD-Ia is approximately 1 in 100,000 to 400,000 births, and it accounts for approximately 25% of all types of glycogen storage disease [ 8 ]. Patients affected by GSD-Ia are unable to maintain glucose homeostasis and present with fasting hypoglycaemia, hepatomegaly, nephromegaly, hyperlipidaemia, hyperuricaemia, lactic acidaemia, and growth retardation [ 9 ]. The diagnosis of this disease mainly depends on clinical manifestations and laboratory examination, assisted by computerized tomography (CT), B-ultrasonography and liver pathology [ 10 , 11 ].…”
Section: Introductionmentioning
confidence: 99%
“…The incidence of GSD-Ia is approximately 1 in 100,000 to 400,000 births, and it accounts for approximately 25% of all types of glycogen storage disease [ 8 ]. Patients affected by GSD-Ia are unable to maintain glucose homeostasis and present with fasting hypoglycaemia, hepatomegaly, nephromegaly, hyperlipidaemia, hyperuricaemia, lactic acidaemia, and growth retardation [ 9 ]. The diagnosis of this disease mainly depends on clinical manifestations and laboratory examination, assisted by computerized tomography (CT), B-ultrasonography and liver pathology [ 10 , 11 ].…”
Section: Introductionmentioning
confidence: 99%